Globally, the number of people suffering from ischemic strokes has increased, especially in developed countries. People suffering from myocardial infarction and stent thrombosis have also gone up. The use of antiplatelet drugs helps in reducing the ability of platelets to stick together and obstructs blood clots formation that leads to these diseases. Thus, its demand has grown significantly in the past few years.
Advancement in pharmaceuticals, proliferation of anticoagulant/antithrombotic drugs, and rising thrombolytic events are the key drivers for the antiplatelet drugs market.

Source: Click here